TSE:CRON

Cronos Group Stock Forecast, Price & News

C$10.60

+0.06 (+0.57 %)

(As of 06/17/2021 12:00 AM ET)

Add

Compare

Today's Range

C$10.47

▼

C$10.80

50-Day Range

C$8.69

▼

C$11.11

52-Week Range

C$6.55

▼

C$20.08

Volume257,810 shs

Average Volume805,581 shs

Market CapitalizationC$3.94 billion

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive CRON News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

About Cronos Group

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Weedmaps CEO isn't afraid of Amazon
June 17, 2021 | msn.com

Cronos Group (TSE:CRON) Stock Rating Reaffirmed by Raymond James
June 15, 2021 | americanbankingnews.com

Marijuana Stocks Fall As Canadian Firms Make More U.S. Inroads
June 14, 2021 | finance.yahoo.com

Cronos Group Acquires 10.5% Ownership Stake In PharmaCann For $110.4M
June 14, 2021 | benzinga.com

Raymond James Reiterates OUTPERFORM Rating for Cronos Group (TSE:CRON)
June 7, 2021 | americanbankingnews.com

Altria's High Dividend Really Is Too Good to Be True
June 7, 2021 | msn.com

Canadian cannabis company Cronos amends agreement with Ginkgo, to issue up to 14.7 million shares
June 4, 2021 | finance.yahoo.com

How Much Of Cronos Group Inc. (TSE:CRON) Do Insiders Own?
June 2, 2021 | finance.yahoo.com

Cronos Group (TSE:CRON) Shares Down 2.9%
June 2, 2021 | americanbankingnews.com

Winning Streak on TSX Cools off a Mite
May 31, 2021 | baystreet.ca

See More Headlines

Industry, Sector and Symbol

Stock Exchange TSE
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolTSE:CRON
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.thecronosgroup.com
Phone416-504-0004
Employees631
Year FoundedN/A

Sales & Book Value

Annual SalesC$50.90 million
Price / Sales77.40
Cash FlowC$3.35 per share
Price / Cash Flow3.16
Book ValueC$4.23 per share
Price / Book2.51

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares371,657,000
Market CapC$3.94 billion
Next Earnings DateN/A
OptionableOptionable

MarketRank^™

Overall MarketRank^™

0.68 out of 5 stars

1.3 Analyst's Opinion

Consensus Rating
Cronos Group has received a consensus rating of Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of C$9.57, Cronos Group has a forecasted downside of 9.7% from its current price of C$10.60.
Amount of Analyst Coverage
Cronos Group has only been the subject of 4 research reports in the past 90 days.

2.1 Community Rank

Outperform Votes
Cronos Group has received 63 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cronos Group has received 85 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cronos Group has received 57.43% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cronos Group and other stocks. Vote “Outperform” if you believe CRON will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CRON will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cronos Group does not currently pay a dividend.
Dividend Growth
Cronos Group does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cronos Group insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Cronos Group is -9.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cronos Group is -9.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
Due to a projected decrease in earnings for Cronos Group, their PEG ratio cannot be calculated.
Price to Book Value per Share Ratio
Cronos Group has a P/B Ratio of 2.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Cronos Group (TSE:CRON) Frequently Asked Questions

Is Cronos Group a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Cronos Group stock.
View analyst ratings for Cronos Group or view top-rated stocks.

What stocks does MarketBeat like better than Cronos Group?

Wall Street analysts have given Cronos Group a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cronos Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Cronos Group's stock been impacted by COVID-19?

Cronos Group's stock was trading at C$7.45 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CRON shares have increased by 42.3% and is now trading at C$10.60.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for CRON?

5 Wall Street analysts have issued twelve-month target prices for Cronos Group's shares. Their forecasts range from C$5.90 to C$13.00. On average, they anticipate Cronos Group's share price to reach C$9.57 in the next twelve months. This suggests that the stock has a possible downside of 9.7%.
View analysts' price targets for Cronos Group or view top-rated stocks among Wall Street analysts.

Who are Cronos Group's key executives?

Cronos Group's management team includes the following people:

Mr. Michael Ryan Gorenstein, Exec. Chairman (Age 34, Pay $493.54k)
Mr. Kurt Thomas Schmidt B.Sc., M.B.A., Pres & CEO (Age 64, Pay $389.62k)
Mr. Jerry Filomena Barbato, Chief Financial Officer (Age 45, Pay $249.24k)
Ms. Xiuming Shum, Exec. VP of Legal and Regulatory Affairs & Corp. Sec. (Age 35, Pay $474.88k)
Ms. Anna Shlimak, Sr. VP of Corp. Affairs (Age 35, Pay $623.3k)
Dr. Todd K. Abraham, Chief Innovation Officer (Age 66, Pay $488.69k)
Mr. Shayne J. Laidlaw, Director of Investor Relations & Strategy
Ms. Shannon Buggy, Sr. VP & Global Head of People (Age 51)
Mr. Jeffrey David Jacobson, Gen. Mang. of Canada & Europe (Age 35)
Ms. Summer Frein, Gen. Mang. of USA (Age 37)

Who are some of Cronos Group's key competitors?

Some companies that are related to Cronos Group include Genus (GNS), BTG (BTG), Abcam (ABC), MorphoSys (MOR), Trillium Therapeutics (TRIL), Concordia International (CXR), Oxford Biomedica (OXB), PureTech Health (PRTC), Biotest Aktiengesellschaft (BIO), Brooklyn ImmunoTherapeutics (BTX), Ergomed (ERGO), Inventiva (IVA), Silence Therapeutics (SLN), Pfenex (PFNX) and Theratechnologies (TH).
View all of CRON's competitors.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), (CGC), Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria (APHA), Advanced Micro Devices (AMD), Netflix (NFLX), The Walt Disney (DIS) and Intel (INTC).

What is Cronos Group's stock symbol?

Cronos Group trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRON."

How do I buy shares of Cronos Group?

Shares of CRON and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately C$10.60.

How much money does Cronos Group make?

Cronos Group has a market capitalization of C$3.94 billion and generates C$50.90 million in revenue each year.

How many employees does Cronos Group have?

Cronos Group employs 631 workers across the globe.

What is Cronos Group's official website?

The official website for Cronos Group is www.thecronosgroup.com.

How can I contact Cronos Group?

The company can be reached via phone at 416-504-0004.

This page was last updated on 6/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here